BIOQUAL, Inc. Announces New CFO

ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL, Inc., Announces Promotion of Mr. Charles (Chris) C. Kirk, Jr., CPA. to the Position of Chief Financial Officer. Mr. Kirk has over 25 years of experience in leadership roles in finance and accounting departments for both Government contracting and services-oriented companies as well as in the public accounting sector. Mr. Kirk has … [Read more…]

Harrow Sells Non-Ophthalmic Compounding Business

NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced the sale of its non‑ophthalmic compounding business to Innovation Compounding Pharmacy, LLC, an affiliate of Revelation Pharma Corporation (“Revelation”). Pursuant to the terms of the transaction, Revelation purchased the assets of Harrow’s … [Read more…]

OrganaBio offers customers a comprehensive inventory of highly characterized cell products.

MIAMI–(BUSINESS WIRE)–#biotech–OrganaBio’s LeukoPAC™ product line includes high quality cryopreserved leukopaks and PBMCs. Extensive donor and product characteristics are provided with every lot, and now researchers can access the cryopreserved inventory and select cells that best fit their specific requirements. Customers can view product inventory and choose products based on donor characteristics such as, gender, age, … [Read more…]

US Kaposi’s Sarcoma Market and Competitive Landscape – 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Kaposi’s Sarcoma Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report US Kaposi’s Sarcoma Market and Competitive Landscape Highlights – 2022, provides comprehensive insights into Kaposi’s Sarcoma pipeline products, Kaposi’s Sarcoma epidemiology, Kaposi’s Sarcoma market valuations and forecast, Kaposi’s Sarcoma drugs sales and competitive landscape in … [Read more…]

Global Fertilizer Sticks Market Report to 2027 – by Type, Application, Nutrient, Distribution Channel and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fertilizer Sticks Market – Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The global fertilizer sticks market is projected to register growth at a formidable rate during the forecast period, 2023-2027. The market growth can be attributed to the growing trend of in-home gardening and … [Read more…]

Indonesia Diagnostic Labs Market Report 2022: Growing Healthcare Expenditure Fueling Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Indonesia Diagnostic Labs Market, By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology v/s Radiology), By End User, By Region, Competition, Forecast & Opportunities, 2017-2027F” report has been added to ResearchAndMarkets.com’s offering. Indonesia diagnostic labs market stood at USD 1,997.95 Million in 2021 and is … [Read more…]

U.S. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028” report from Plunkett Research Ltd has been added to ResearchAndMarkets.com’s offering. Benchmarks Historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing … [Read more…]

LadRx Corporation Announces OTCQB Ticker Change to LADX

LOS ANGELES–(BUSINESS WIRE)–LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, October 6, 2022. Chief Executive Officer Stephen Snowdy, PhD commented, “Following up on other changes we have made … [Read more…]

Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at Upcoming Society for Immunotherapy of Cancer Annual Meeting

DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that results from the Company’s ongoing preclinical studies evaluating targeted immunotherapy for cancer based on the Manocept platform have been accepted for presentation at the 37th Annual Meeting of … [Read more…]

Largest Lead Health Home in New York State Chooses Foothold as Its Technology Partner

The Health Home Divisions of Sun River Health and Community Healthcare Network Have Merged to Form Skyward Health, the Largest Lead Health Home in New York State, and Have Selected Foothold as Their Technology Partner NEW YORK–(BUSINESS WIRE)–Today, Foothold Technology (“Foothold”) announced a new partnership with Skyward Health (“Skyward”). This partnership will enable Skyward to … [Read more…]